{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:48:34Z","timestamp":1721209714594},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,11,15]]},"DOI":"10.18632\/aging.205157","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T15:51:39Z","timestamp":1698940299000},"page":"11918-11939","source":"Crossref","is-referenced-by-count":2,"title":["The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjia","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","article-title":"Pre-clinical modeling of cutaneous melanoma.","volume":"1","author":"Herlyn","year":"2020","journal-title":"Nat Commun"},{"key":"3","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3390\/jcm11082239","article-title":"Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence.","volume":"1","author":"Zeme\u0142ka","year":"2022","journal-title":"J Clin Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"880876","DOI":"10.3389\/fonc.2022.880876","article-title":"Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter.","volume":"1","author":"Ahmad","year":"2022","journal-title":"Front Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/07357907.2016.1245317","article-title":"Hypoxia: A Double-Edged Sword in Cancer Therapy.","volume":"3","author":"Najafi","year":"2016","journal-title":"Cancer Invest"},{"key":"6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molmed.2012.08.001","article-title":"Molecular mechanisms mediating metastasis of hypoxic breast cancer cells.","volume":"1","author":"Semenza","year":"2012","journal-title":"Trends Mol Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-319-91287-5_27","article-title":"Hypoxia-\/HIF-1\u03b1-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.","volume":"107","author":"Multhoff","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.18632\/oncotarget.27780","article-title":"Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.","volume":"1","author":"Sodhi","year":"2021","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment.","volume":"1","author":"Shu","year":"2019","journal-title":"Mol Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.32419","article-title":"Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.","volume":"7","author":"Soon","year":"2022","journal-title":"Hepatology"},{"key":"12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41416-021-01600-w","article-title":"Long non-coding RNAs are involved in alternative splicing and promote cancer progression.","volume":"12","author":"Zhang","year":"2022","journal-title":"Br J Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/02648725.2018.1471566","article-title":"Long noncoding RNAs: regulation, function and cancer.","volume":"3","author":"Nuri","year":"2018","journal-title":"Biotechnol Genet Eng Rev"},{"key":"14","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long Noncoding RNA and Cancer: A New Paradigm.","volume":"7","author":"Mandal","year":"2017","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/15476286.2020.1737787","article-title":"The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.","volume":"1","author":"Zhang","year":"2020","journal-title":"RNA Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment.","volume":"2","author":"Tackett","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"17","doi-asserted-by":"publisher","first-page":"e1010081","DOI":"10.1371\/journal.pcbi.1010081","article-title":"LncRNAs of Saccharomyces cerevisiae bypass the cell cycle arrest imposed by ethanol stress.","volume":"1","author":"Valente","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/pcmr.12926","article-title":"The tumour immune landscape and its implications in cutaneous melanoma.","volume":"3","author":"Scolyer","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"1","author":"He","year":"2012","journal-title":"OMICS"},{"key":"20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis.","volume":"1","author":"Corazzari","year":"2019","journal-title":"Cell Death Dis"},{"key":"21","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/cancers14153587","article-title":"Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma.","volume":"1","author":"Egyhazi Brage","year":"2022","journal-title":"Cancers (Basel)"},{"key":"22","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/s41433-022-02057-8","article-title":"Melanoma-associated retinopathy after starting immunotherapy for metastatic cutaneous melanoma.","volume":"3","author":"Kotagiri","year":"2022","journal-title":"Eye (Lond)"},{"key":"23","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.","volume":"10","author":"Allison","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fonc.2018.00173","article-title":"Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.","volume":"8","author":"Haass","year":"2018","journal-title":"Front Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/cancers12102870","article-title":"Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy.","volume":"1","author":"Milella","year":"2020","journal-title":"Cancers (Basel)"},{"key":"26","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1007\/s12094-021-02597-7","article-title":"Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.","volume":"2","author":"Kashyap","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"111873","DOI":"10.1016\/j.biopha.2021.111873","article-title":"The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma.","volume":"14","author":"Sheida","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"28","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1172\/JCI137553","article-title":"Hypoxia-inducible factors and innate immunity in liver cancer.","volume":"13","author":"Wong","year":"2020","journal-title":"J Clin Invest"},{"key":"29","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/1878-0261.12747","article-title":"Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.","volume":"1","author":"Xie","year":"2020","journal-title":"Mol Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"e12423","DOI":"10.1111\/cpr.12423","article-title":"ZEB1-AS1: A crucial cancer-related long non-coding RNA.","volume":"5","author":"Jiang","year":"2018","journal-title":"Cell Prolif"},{"key":"31","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.18632\/aging.103075","article-title":"Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression.","volume":"1","author":"Peng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-018-0758-8","article-title":"Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression.","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"33","doi-asserted-by":"publisher","first-page":"8848227","DOI":"10.1155\/2021\/8848227","article-title":"A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.","volume":"202","author":"Feng","year":"2021","journal-title":"Biomed Res Int"},{"key":"34","doi-asserted-by":"publisher","first-page":"15624","DOI":"10.18632\/aging.103718","article-title":"An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.","volume":"1","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3892\/ol.2021.12766","article-title":"Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.","volume":"2","author":"Zhao","year":"2021","journal-title":"Oncol Lett"},{"key":"36","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/s41598-021-81641-6","article-title":"LncRNA EBLN3P promotes the progression of osteosarcoma through modifying the miR-224-5p\/Rab10 signaling axis.","volume":"1","author":"Zhang","year":"2021","journal-title":"Sci Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/tcr-21-1554","article-title":"A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma.","volume":"1","author":"Wang","year":"2022","journal-title":"Transl Cancer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"692170","DOI":"10.3389\/fonc.2021.692170","article-title":"Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes.","volume":"1","author":"Carvalho de Oliveira","year":"2021","journal-title":"Front Oncol"},{"key":"39","doi-asserted-by":"publisher","first-page":"651600","DOI":"10.3389\/fmed.2021.651600","article-title":"Long Non-coding RNA EBLN3P Regulates UHMK1 Expression by Sponging miR-323a-3p and Promotes Colorectal Cancer Progression.","volume":"8","author":"Shen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/mmr.2021.12558","article-title":"Analysis of differentially expressed long non-coding RNAs revealed a pro-tumor role of MIR205HG in cervical cancer.","volume":"2","author":"Zheng","year":"2022","journal-title":"Mol Med Rep"},{"key":"41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.ki.5002792","article-title":"Hypoxia stimulus: An adaptive immune response during dendritic cell maturation.","volume":"7","author":"Griny\u00f3","year":"2008","journal-title":"Kidney Int"},{"key":"42","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3390\/cancers14092291","article-title":"Hypoxia as a Modulator of Inflammation and Immune Response in Cancer.","volume":"1","author":"D\u00e1vila-Borja","year":"2022","journal-title":"Cancers (Basel)"},{"key":"43","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1002\/mco2.203","article-title":"Hypoxia signaling in cancer: Implications for therapeutic interventions.","volume":"4","author":"Wu","year":"2023","journal-title":"MedComm (2020)"},{"key":"44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.","volume":"21","author":"Chouaib","year":"2014","journal-title":"J Exp Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/hep.32062","article-title":"IL-1\u03b2-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.","volume":"7","author":"Xia","year":"2021","journal-title":"Hepatology"},{"key":"46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s1535-6108(03)00194-6","article-title":"The hypoxic response of tumors is dependent on their microenvironment.","volume":"4","author":"Bergers","year":"2003","journal-title":"Cancer Cell"},{"key":"47","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.29681","article-title":"Hypoxia-inducible factor-1\u03b1\/interleukin-1\u03b2 signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.","volume":"6","author":"Liang","year":"2018","journal-title":"Hepatology"},{"key":"48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1164\/rccm.201310-1830OC","article-title":"Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.","volume":"18","author":"Gozal","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8349-8","article-title":"Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function.","volume":"5","author":"Clambey","year":"2013","journal-title":"Immunol Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41590-022-01210-5","article-title":"Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3.","volume":"2","author":"Das","year":"2022","journal-title":"Nat Immunol"},{"key":"51","doi-asserted-by":"publisher","first-page":"108779","DOI":"10.1016\/j.clim.2021.108779","article-title":"Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency.","volume":"22","author":"Hauck","year":"2021","journal-title":"Clin Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40880-017-0226-3","article-title":"Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.","volume":"3","author":"Hong","year":"2017","journal-title":"Chin J Cancer"},{"key":"53","doi-asserted-by":"publisher","first-page":"7044","DOI":"10.1002\/cam4.2542","article-title":"MACC1 regulates PDL1 expression and tumor immunity through the c-Met\/AKT\/mTOR pathway in gastric cancer cells.","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:06:03Z","timestamp":1700510763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":53,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11,15]]}},"alternative-id":["205157","37921852"],"URL":"https:\/\/doi.org\/10.18632\/aging.205157","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}